Search Results - "Schornagel, J" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours

Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours

by Sternberg, C.N., de Mulder, P., Schornagel, J.H., Theodore, C., Fossa, S.D., van Oosterom, A.T., Witjes, J.A., Spina, M., van Groeningen, C.J., Duclos, B., Roberts, J.T., de Balincourt, C., Collette, L.
Published in European journal of cancer (1990) (2006)

Get full text

Journal Article

Randomized Phase III Trial of High–Dose-Intensity Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (MVAC) Chemotherapy and Recombinant Human Granulocyte Colony-Stimulating Factor Versus Classic MVAC in Advanced Urothelial Tract Tumors: European Organization for Research and Treatment of Cancer Protocol No. 30924

Randomized Phase III Trial of High–Dose-Intensity Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (MVAC) Chemotherapy and Recombinant Human Granulocyte Colony-Stimulating Factor Versus Classic MVAC in Advanced Urothelial Tract Tumors: European Organization for Research and Treatment of Cancer Protocol No. 30924

by STERNBERG, C. N, DE MULDER, P. H. M, COLLETTE, L, SCHORNAGEL, J. H, THEODORE, C, FOSSA, S. D, VAN OOSTEROM, A. T, WITJES, F, SPINA, M, VAN GROENINGEN, C. J, DE BALINCOURT, C
Published in Journal of clinical oncology (15.05.2001)

Get full text

Journal Article

How Are You Feeling? Who Wants To Know? Patients’ and Oncologists’ Preferences for Discussing Health-Related Quality-of-Life Issues

How Are You Feeling? Who Wants To Know? Patients’ and Oncologists’ Preferences for Discussing Health-Related Quality-of-Life Issues

by DETMAR, S. B, AARONSON, N. K, WEVER, L. D, MULLER, M, SCHORNAGEL, J. H
Published in Journal of clinical oncology (15.09.2000)

Get full text

Journal Article

Determinants of the elimination of methotrexate and 7‐hydroxy‐methotrexate following high‐dose infusional therapy to cancer patients

Determinants of the elimination of methotrexate and 7‐hydroxy‐methotrexate following high‐dose infusional therapy to cancer patients

by Joerger, M., Huitema, A. D. R., Van Den Bongard, H. J. G. D., Baas, P., Schornagel, J. H., Schellens, J. H. M., Beijnen, J. H.
Published in British journal of clinical pharmacology (01.07.2006)

Get full text

Journal Article

Evaluating the quality of life of cancer patients: assessments by patients, significant others, physicians and nurses

Evaluating the quality of life of cancer patients: assessments by patients, significant others, physicians and nurses

by SNEEUW, K. C. A, AARONSON, N. K, SPRANGERS, M. A. G, DETMAR, S. B, WEVER, L. D. V, SCHORNAGEL, J. H
Published in British Journal of Cancer (01.09.1999)

Get full text

Journal Article

Neoadjuvant methotrexate, vinblastine, doxorubicin and cisplatin for histologically proven lymph node positive bladder cancer

Neoadjuvant methotrexate, vinblastine, doxorubicin and cisplatin for histologically proven lymph node positive bladder cancer

by Nieuwenhuijzen, J A, Bex, A, Meinhardt, W, Kerst, J M, Schornagel, J H, VAN Tinteren, H, Horenblas, S
Published in The Journal of urology (01.07.2005)

Get more information

Journal Article

Punch biopsies in tattooed skin: Complications and patient‐reported outcomes

Punch biopsies in tattooed skin: Complications and patient‐reported outcomes

by Poelhekken, Mila, Schornagel, Ines J., Bent, Sebastiaan A. S.
Published in JEADV clinical practice (01.09.2024)

Get full text

Journal Article

Role of health-related quality of life in palliative chemotherapy treatment decisions

Role of health-related quality of life in palliative chemotherapy treatment decisions

by DETMAR, S. B, MULLER, M. J, SCHORNAGEL, J. H, WEVER, L. D. V, AARONSON, N. K
Published in Journal of clinical oncology (15.02.2002)

Get full text

Journal Article

Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement

Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement

by Rodenhuis, Sjoerd, Richel, Dick J, van der Wall, Elsken, Schornagel, Jan H, Baars, Joke W, Koning, Caro CE, Peterse, Johannes L, Borger, Jacques H, Nooijen, Willem J, Bakx, Roel, Dalesio, Otilia, Rutgers, Emiel
Published in The Lancet (British edition) (15.08.1998)

Get full text

Journal Article

Phase II and pharmacological study of oral paclitaxel (Paxoral) plus ciclosporin in anthracycline-pretreated metastatic breast cancer

Phase II and pharmacological study of oral paclitaxel (Paxoral) plus ciclosporin in anthracycline-pretreated metastatic breast cancer

by HELGASON, H. H, KRUIJTZER, C. M. F, HUITEMA, A. D. R, MARCUS, S. G, TEN BOKKEL HUININK, W. W, SCHOT, M. E, SCHORNAGEL, J. H, BEIJNEN, J. H, SCHELLENS, J. H. M
Published in British journal of cancer (09.10.2006)

Get full text

Journal Article

Phase I Clinical and Pharmacokinetic Study of Oral S-1 in Patients With Advanced Solid Tumors

Phase I Clinical and Pharmacokinetic Study of Oral S-1 in Patients With Advanced Solid Tumors

by VAN GROENINGEN, C. J, PETERS, G. J, GIACCONE, G, SCHORNAGEL, J. H, GALL, H, NOORDHUIS, P, DE VRIES, M. J, TURNER, S. L, SWART, M. S, PINEDO, H. M, HANAUSKE, A. R
Published in Journal of clinical oncology (01.07.2000)

Get full text

Journal Article

Value of caregiver ratings in evaluating the quality of life of patients with cancer

Value of caregiver ratings in evaluating the quality of life of patients with cancer

by Sneeuw, K C, Aaronson, N K, Sprangers, M A, Detmar, S B, Wever, L D, Schornagel, J H
Published in Journal of clinical oncology (01.03.1997)

Get more information

Journal Article

Randomized trial of high-dose chemotherapy and hematopoietic progenitor-cell support in operable breast cancer with extensive lymph node involvement: final analysis with 7 years of follow-up

Randomized trial of high-dose chemotherapy and hematopoietic progenitor-cell support in operable breast cancer with extensive lymph node involvement: final analysis with 7 years of follow-up

by Schrama, J. G., Faneyte, I. F., Schornagel, J. H., Baars, J. W., Peterse, J. L., van de Vijver, M. J., Dalesio, O., van Tinteren, H., Rutgers, E. J. T., Richel, D. J., Rodenhuis, S.
Published in Annals of oncology (01.05.2002)

Get full text

Journal Article

Comparison of Patient and Proxy EORTC QLQ-C30 Ratings in Assessing the Quality of Life of Cancer Patients

Comparison of Patient and Proxy EORTC QLQ-C30 Ratings in Assessing the Quality of Life of Cancer Patients

by Sneeuw, Kommer C.A., Aaronson, Neil K., Sprangers, Mirjam A.G., Detmar, Symone B., Wever, Lidwina D.V., Schornagel, Jan H.
Published in Journal of clinical epidemiology (01.07.1998)

Get full text

Journal Article

For Large Lateralized Head and Neck Tumors Intra-arterial Chemoradiation is Superior to Intravenous Chemoradiation

For Large Lateralized Head and Neck Tumors Intra-arterial Chemoradiation is Superior to Intravenous Chemoradiation

by Rasch, C, Hauptmann, M, Schornagel, J, Kröger, R, Balm, A.J.M
Published in International journal of radiation oncology, biology, physics (2008)

Get full text

Journal Article

Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative Group

Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative Group

by Clavel, M, Vermorken, J B, Cognetti, F, Cappelaere, P, de Mulder, P H, Schornagel, J H, Tueni, E A, Verweij, J, Wildiers, J, Clerico, M
Published in Annals of oncology (01.07.1994)

Get full text

Journal Article

Endocytosis of GPI-Linked Membrane Folate Receptor-α

Endocytosis of GPI-Linked Membrane Folate Receptor-α

by Rijnboutt, Simon, Jansen, Gerrit, Posthuma, George, Hynes, John B., Schornagel, Jan H., Strous, Ger J.
Published in The Journal of cell biology (01.01.1996)

Get full text

Journal Article

Toxicity of the high-dose chemotherapy CTC regimen (cyclophosphamide, thiotepa, carboplatin): the Netherlands Cancer Institute experience

Toxicity of the high-dose chemotherapy CTC regimen (cyclophosphamide, thiotepa, carboplatin): the Netherlands Cancer Institute experience

by SCHRAMA, J. G, HOLTKAMP, M. J, BAARS, J. W, SCHORNAGEL, J. H, RODENHUIS, S
Published in British journal of cancer (16.06.2003)

Get full text

Journal Article

Pharmacokinetics of S-1, an oral formulation of ftorafur, oxonic acid and 5-chloro-2,4-dihydroxypyridine (molar ratio 1:0.4:1) in patients with solid tumors

Pharmacokinetics of S-1, an oral formulation of ftorafur, oxonic acid and 5-chloro-2,4-dihydroxypyridine (molar ratio 1:0.4:1) in patients with solid tumors

by PETERS, G. J, NOORDHUIS, P, HOLWERDA, U, GIACCONE, K. Smid G, FUMOLEAU, P, VAN GROENINGEN, C. J, VAN KUILENBURG, A. B. P, SCHORNAGEL, J. H, GALL, H, TURNER, S. L, SWART, M. S, VOORN, D, VAN GENNIP, A. H, WANDERS, J
Published in Cancer chemotherapy and pharmacology (01.07.2003)

Get full text

Journal Article

Feasibility of multiple courses of high-dose cyclophosphamide, thiotepa, and carboplatin for breast cancer or germ cell cancer

Feasibility of multiple courses of high-dose cyclophosphamide, thiotepa, and carboplatin for breast cancer or germ cell cancer

by Rodenhuis, S, Westermann, A, Holtkamp, M J, Nooijen, W J, Baars, J W, van der Wall, E, Slaper-Cortenbach, I C, Schornagel, J H
Published in Journal of clinical oncology (01.05.1996)

Get more information

Journal Article

1
2
3
4
5
6
7
8
9
Next
[9]